The analysis involved patients in the investigational device exemption study assessing Medtronic’s Prestige cervical disc.
The Spine Journal published the study.
Here are six notes:
1. In the base-case analysis, the researchers found a 40-year-old experienced a five-year cost of:
• $116,717 for ACDF
• $130,417 for CDR
2. CDR yielded 3.45 quality-adjusted life years and ACDF saw 3.23 QALYS.
3. The study revealed CDR’s incremental cost-effectiveness ratio was $62,337 per QALY.
4. Researchers found the Monte Carlo simulation validated the base-case scenario.
5. Based on a $100,000 per QALY willingness to pay, CDR proved to be more cost-effective.
6. The researchers concluded both two-level CDR and ACDF are cost-effective at five years.
More articles on spine:
Texas Medical Board suspends neurosurgeon’s license following child sexual assault arrest: 5 key notes
Jeopardy! host undergoes surgery to remove subdural hematoma: 4 things to know
Top 10 Spine Review articles: Jan. 1-5
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
